Matthew James Pianko, MD

Matthew James Pianko, MD

Specialty: Hematology, Medical Oncology, Internal Medicine
Title: Clinical Associate Professor
5/5
See All Ratings

To request an appointment call

734-647-8902
Matthew James Pianko, MD
Matthew James Pianko, MD
Hematology
  • About
  • Areas of Practice
  • Expertise
  • Locations
  • Insurance
  • Education & Training
  • Research Overview
  • Links
  • Patient Ratings & Comments
  • Manage Your Profile

  • About

    Languages: English, Spanish
    Activities: Running, Cycling.
    Awards: 2023 Castle Connolly Top Doctor

    Areas of Practice

    I am a hematologist focused on the care of patients with plasma cell disorders, including Multiple Myeloma, Smoldering Multiple Myeloma, Light chain (AL) amyloidosis, Plasma Cell Leukemia, Monoclonal Gammopathy of Undetermined Significance (MGUS), POEMS syndrome, and Monoclonal Gammopathy of Renal Significance (MGRS). I am committed to providing compassionate patient-centered care for patients with myeloma and other plasma cell disorders.

    Locations

    • Myeloma Clinic | Rogel Cancer Center 1500 E Medical Center Dr
      Floor B1 Reception A
      Ann Arbor, MI 48109-5911
      Get Directions

    Insurance Accepted

    University of Michigan Health participates with most health insurance plans.

    See our insurance details

    Education & Training

    Medical School or Training

    Stanford University School of Medicine, 2011

    Residency

    Columbia University College of Physicians & Surgeons, Internal Medicine, 2014

    Fellowships

    Memorial Sloan Kettering Cancer Center, Hematology/Medical Oncology, 2018

    Board Certifications

    Internal Medicine
    Hematology
    Medical Oncology

    Professional Organizations

    American Society of Clinical Oncology
    American Society of Hematology
    Gold Humanism Honor Society
    Michigan Society of Hematology and Oncology
    Society of Hematology and Oncology
    International Myeloma Society

    Research Overview

    I am involved in exploring new drugs and new drug combinations for patients with multiple myeloma through participating in and leading clinical trials in this area. At UM, I serve as the co-chair for the Hematologic Malignancies Clinical Research Team. I also serve as the co-chair of the Big Ten Cancer Research Consortium Multiple Myeloma Clinical Trials working group.

    Links

    Michigan Research Experts Website

    Patient Ratings & Comments

    Visit our Physician Ratings & Comments page to learn more about how patient ratings are collected, calculated, and updated to help you make an informed decision when choosing the right physician for your care.

    Patient Ratings

    233 Patient Ratings

    Patient Comments

    February 27, 2026 - "I feel very confident having Dr Pianko taking care of my health condition"

    January 22, 2026 - "Dr. Pianko has been, continues to be, a powerful advocate as I navigate [...]"

    December 10, 2025 - "Dr. Pianko is good. I will recommend him if required to others."

    October 9, 2025 - "Dr Pianko is a gem! Simply the best!"

    October 9, 2025 - "Dr. Pianko is the BEST!"

    October 2, 2025 - "Dr.Pianko is a compassionate and knowledgeable professional. I am grateful that he is a part of my recovery team."

    September 4, 2025 - "Dr Pianko is an outstanding doctor and very caring. In [...] I called him to tell him of my [...] diagnosis. The next morning he sent me referrals to surgeon setting in motion all the tests I needed. I am so grateful to him."

    June 26, 2025 - "Dr. Pianko [...] is a fantastic doctor. I was once concerned about a health issue and got the most thoroughly researched answer on the portal that I have ever received from any doctor. He is one of a kind in my experience (and I am almost [...] years old). He is a gem. He is so good [...]"

    June 26, 2025 - "Dr Pianko was great as usual!"

    June 5, 2025 - "Dr. Pianko is a specialist treating my [...]. He is an outstanding Dr., one of the best. He has knowledge of the cutting edge developments in [...]. He is compassionate and coordinated my care with others doctors in my recent [...] diagnosis. I am so fortunate to be with such a compassionate and knowledgeable doctor."

    Show All Comments

    Featured News & Stories

    man on white bed in blue pajamas with iv pole behind him neutral expression on face
    Health Lab

    2 multiple myeloma treatments receive FDA approval

    The Food and Drug Administration approved two drugs—daratumumab and linvoseltamab—for precursor conditions to multiple myeloma and relapsed multiple myeloma. Matthew Pianko answers questions about the current treatment options for multiple myeloma, the new FDA-approved drugs and what these treatments mean for patients.
    Health Lab

    4 exciting advances in multiple myeloma

    A specialist outlines some recent advances that have him excited for the future of multiple myeloma treatment.